Cite
Spirodiketopiperazine-based CCR5 antagonist: discovery of an antiretroviral drug candidate.
MLA
Nishizawa, Rena, et al. “Spirodiketopiperazine-Based CCR5 Antagonist: Discovery of an Antiretroviral Drug Candidate.” Bioorganic & Medicinal Chemistry Letters, vol. 21, no. 4, Feb. 2011, pp. 1141–45. EBSCOhost, https://doi.org/10.1016/j.bmcl.2010.12.109.
APA
Nishizawa, R., Nishiyama, T., Hisaichi, K., Minamoto, C., Matsunaga, N., Takaoka, Y., Nakai, H., Jenkinson, S., Kazmierski, W. M., Tada, H., Sagawa, K., Shibayama, S., Fukushima, D., Maeda, K., & Mitsuya, H. (2011). Spirodiketopiperazine-based CCR5 antagonist: discovery of an antiretroviral drug candidate. Bioorganic & Medicinal Chemistry Letters, 21(4), 1141–1145. https://doi.org/10.1016/j.bmcl.2010.12.109
Chicago
Nishizawa, Rena, Toshihiko Nishiyama, Katsuya Hisaichi, Chiaki Minamoto, Naoki Matsunaga, Yoshikazu Takaoka, Hisao Nakai, et al. 2011. “Spirodiketopiperazine-Based CCR5 Antagonist: Discovery of an Antiretroviral Drug Candidate.” Bioorganic & Medicinal Chemistry Letters 21 (4): 1141–45. doi:10.1016/j.bmcl.2010.12.109.